1. Home
  2. GHG vs ANIX Comparison

GHG vs ANIX Comparison

Compare GHG & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GHG

GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share

N/A

Current Price

$1.06

Market Cap

101.9M

ML Signal

N/A

Logo Anixa Biosciences Inc.

ANIX

Anixa Biosciences Inc.

N/A

Current Price

$2.80

Market Cap

103.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GHG
ANIX
Founded
2004
1982
Country
China
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
101.9M
103.9M
IPO Year
2017
2013

Fundamental Metrics

Financial Performance
Metric
GHG
ANIX
Price
$1.06
$2.80
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $9.67
AVG Volume (30 Days)
44.9K
★ 177.6K
Earning Date
12-22-2026
09-09-2026
Dividend Yield
★ 5.77%
N/A
EPS Growth
N/A
★ 12.82
EPS
★ N/A
N/A
Revenue
N/A
★ $210,000.00
Revenue This Year
$56.17
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$5.76
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.91
$2.32
52 Week High
$1.99
$5.46

Technical Indicators

Market Signals
Indicator
GHG
ANIX
Relative Strength Index (RSI) 58.20 43.75
Support Level $0.92 $2.51
Resistance Level $1.13 $3.09
Average True Range (ATR) 0.07 0.24
MACD 0.01 -0.02
Stochastic Oscillator 78.94 7.86

Price Performance

Historical Comparison
GHG
ANIX

About GHG GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share

GreenTree Hospitality Group Ltd is a franchised hotel operator in China as franchised and managed hotels represent almost all the hotels in its hotel network. The company operates its hotels under GreenTree Inns, GreenTree Eastern, Gme, Gya and VX, GreenTree Alliance, Vatica, and others. The Group reports its financial results in two operating segments: Hotel Business, which consists of leased-and-operated hotels and franchised-and-managed hotels operating under the hotel related brand, and Restaurant Business, which consists of leased-and-operated restaurants and franchised-and-managed restaurants operating under the brands of Da Niang and Bellagio. It derives maximum revenue from Hotel Business segment. It operates solely in China and generates all its revenue from China itself.

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.

Share on Social Networks: